porno izle
porno
asyabahis
women desperate to piss ava addams mom porn sa akin ang gabi
sisli escort mecidiyekoy escort

Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



Rebecca Wilkes's Articles

AMSBIO: Heparan Sulfate Products for COVID-19 Research

AMSBIO offer a wide range of Heparan Sulfate antibodies, enzymes, standards and ready-to-use Heparanase activity assays for researchers seeking to better understand COVID-19 and thereby to combat the pandemic.

Arctoris announces new Advisory Board members to further strengthen robotics-powered drug discovery

Arctoris Ltd, an Oxford-based research company operating a fully automated drug discovery platform, has appointed three distinguished experts as members of its Advisory Board: Beth J Hoffman PhD, Professor Khusru Asadullah MD, and Stanley Lapidus.

Absolute Antibody: International Consortium Awarded Eurostars Grant for the Development of First-in-class Treatment of Metastatic Cancer

ONA Therapeutics, Absolute Antibody and RIC - three leading European companies in the biotech landscape - have been awarded a Eurostars grant for a two-year project that will develop a proprietary biological drug with a unique mode of action for the treatment of various types of metastatic cancers

End of October 2020

Birmingham spinout Revitope Oncology Inc announces $10m investment

University of Birmingham spinout Revitope Oncology Inc has announced a $10m investment from leading Chinese biopharmaceutical company Junshi Biosciences.

AMSBIO: Novel Cell Therapy for Liver Cirrhosis

AMSBIO has published an interview with researchers at Yamaguchi University Graduate School of Medicine, Department of Gastroenterology and Hepatology, Japan, that covers their groundbreaking work to develop cell regeneration therapies for liver cirrhosis.

BIOCITY: Hot flushes may become a thing of the past, as Astinno wins East Midlands AHSN Accelerator

On 25 November, five pioneering life science start-ups pitched to a panel of investors as they completed the final part of their journey on the East Midlands AHSN Accelerator, delivered by BioCity.

Enara Bio relocates to The Oxford Science Park’s newest facility to expand R&D capabilities in the search for novel cancer immunotherapies

Enara Bio, a biotechnology company leveraging its proprietary T-cell/T-cell receptor (TCR) discovery and Dark Antigen™ platforms to deliver targeted cancer immunotherapies, announces its expansion and move to the new Bellhouse Building at The Oxford Science Park.

Milton Park refreshes brand identity for a changing world and 2040 Vision

Milton Park in Oxfordshire, one of Europe’s largest science and technology communities, has refreshed its brand values and identity to reflect the way in which the world has changed in 2020 and enable it to continue to communicate its 2040 Vision, its pioneering masterplan for how the Park will sustainably grow from 9,000 people to 20,000 people.

University of Birmingham Enterprise: Spinout 4D Biomaterials ramps up commercialisation for 3D tissue scaffolds

2 December, 20204D Biomaterials has been awarded funding by Innovate UK for the development and commercialisation of a new class of liquid resins that can be custom-printed into bioresorbable 3D tissue scaffolds providing accelerated and improved wound healing following major surgery. 

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.